Working at Merus provides you with opportunities to grow and develop a career that offers both individual and company success. You will have the chance to make an impact within the oncology field by helping to the Company progress its clinical-stage bispecific antibody candidates (Biclonics®) in the potential treatment of cancer. Merus’ headquarters are located in the Netherlands, but we also have offices in the US and collaborations around the world. As of 2016 we are listed on the NASDAQ Stock Market and to date have three therapeutic candidate in clinical development. For more information, please visit www.merus.nl.